Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/92843
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gaspar, M. C. | - |
dc.contributor.author | Couet, W. | - |
dc.contributor.author | Olivier, J.-C. | - |
dc.contributor.author | Pais, A. A. C. C. | - |
dc.contributor.author | Sousa, J. J. S. | - |
dc.date.accessioned | 2021-02-02T10:42:32Z | - |
dc.date.available | 2021-02-02T10:42:32Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 0934-9723 | pt |
dc.identifier.issn | 1435-4373 | pt |
dc.identifier.uri | https://hdl.handle.net/10316/92843 | - |
dc.description.abstract | Cystic fibrosis (CF) is a complex inherited disease which affects many organs, including the pancreas and liver, gastrointestinal tract and reproductive system, sweat glands and, particularly, the respiratory system. Pseudomonas aeruginosa is the main cause of chronic airway infection. In order to reduce morbidity and mortality due to lung infection by P. aeruginosa, aerosol antibiotics have been used to achieve high local concentrations in the airways and to reduce systemic toxicity. In the course of this review, the current treatments to control CF lung infections by P. aeruginosa are presented. Some innovative aerosol formulations such as liposomes and microspheres are herein reviewed, which may improve the efficiency of anti-pseudomonal agents, and ensure patients' compliance to treatments, by reducing dosing frequency and/or drug dose, while maintaining therapeutic efficacy, preventing the occurrence of bacterial resistance and/or reducing adverse effects due to their controlled-release properties. | pt |
dc.language.iso | eng | pt |
dc.publisher | Springer | pt |
dc.relation | info:eu-repo/grantAgreement/FCT/SFRH/SFRH/BD/80307/2011/PT/PULMONARY TARGETING AND BIOPHARMACEUTICAL EVALUATIONS OF ANTI-INFECTIVE DRUGS ADMINISTERED AS INNOVATIVE MICROSPHERE AEROSOLS | pt |
dc.rights | openAccess | pt |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt |
dc.subject.mesh | Administration, Inhalation | pt |
dc.subject.mesh | Aerosols | pt |
dc.subject.mesh | Anti-Bacterial Agents | pt |
dc.subject.mesh | Bronchopneumonia | pt |
dc.subject.mesh | Cystic Fibrosis | pt |
dc.subject.mesh | Humans | pt |
dc.subject.mesh | Pseudomonas Infections | pt |
dc.subject.mesh | Pseudomonas aeruginosa | pt |
dc.title | Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: A review | pt |
dc.type | article | - |
degois.publication.firstPage | 1231-1252 | pt |
degois.publication.lastPage | 1252 | pt |
degois.publication.issue | 10 | pt |
degois.publication.title | European Journal of Clinical Microbiology & Infectious Diseases | pt |
dc.relation.publisherversion | https://link.springer.com/article/10.1007/s10096-013-1876-y | pt |
dc.peerreviewed | yes | pt |
dc.identifier.doi | 10.1007/s10096-013-1876-y | pt |
degois.publication.volume | 32 | pt |
dc.date.embargo | 2013-01-01 | * |
uc.date.periodoEmbargo | 0 | pt |
item.fulltext | Com Texto completo | - |
item.grantfulltext | open | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
item.openairetype | article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.researchunit | CIEPQPF – Chemical Process Engineering and Forest Products Research Centre | - |
crisitem.author.researchunit | CQC - Coimbra Chemistry Centre | - |
crisitem.author.researchunit | CQC - Coimbra Chemistry Centre | - |
crisitem.author.parentresearchunit | Faculty of Sciences and Technology | - |
crisitem.author.parentresearchunit | Faculty of Sciences and Technology | - |
crisitem.author.parentresearchunit | Faculty of Sciences and Technology | - |
crisitem.author.orcid | 0000-0002-5584-6324 | - |
crisitem.author.orcid | 0000-0002-6725-6460 | - |
crisitem.author.orcid | 0000-0001-9718-8035 | - |
Appears in Collections: | FFUC- Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Gaspar et al, 2013.pdf | 603.71 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
80
checked on Nov 9, 2022
WEB OF SCIENCETM
Citations
73
checked on Aug 2, 2022
Page view(s)
166
checked on Sep 24, 2024
Download(s)
521
checked on Sep 24, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License